- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2001-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma ; volume:8 ; number:1 ; day:1 ; month:4 ; year:2019 ; pages:1-17 ; date:12.2019
Clinical and translational medicine ; 8, Heft 1 (1.4.2019), 1-17, 12.2019
- Urheber
-
Daniel, S. K.
Sullivan, K. M.
Labadie, K. P.
Pillarisetty, V. G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40169-019-0226-9
- URN
-
urn:nbn:de:101:1-2019041200341507959713
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Daniel, S. K.
- Sullivan, K. M.
- Labadie, K. P.
- Pillarisetty, V. G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
BNIP3+ fibroblasts associated with hypoxia and inflammation predict prognosis and immunotherapy response in pancreatic ductal adenocarcinoma
Barriers and opportunities in pancreatic cancer immunotherapy
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia
Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy
Cellular immunotherapy of pancreatic ductal adenocarcinoma: Discovery and evaluation of novel target candidates
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy
Clinical immunotherapy in pancreatic cancer
Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma
Models of pancreatic ductal adenocarcinoma
Novel tumor suppressors in pancreatic adenocarcinoma
Advanced pancreatic ductal adenocarcinoma : moving forward
BNIP3+ fibroblasts associated with hypoxia and inflammation predict prognosis and immunotherapy response in pancreatic ductal adenocarcinoma
Barriers and opportunities in pancreatic cancer immunotherapy
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia
Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy
Cellular immunotherapy of pancreatic ductal adenocarcinoma: Discovery and evaluation of novel target candidates
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy
Clinical immunotherapy in pancreatic cancer
Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma
Models of pancreatic ductal adenocarcinoma
Novel tumor suppressors in pancreatic adenocarcinoma
Advanced pancreatic ductal adenocarcinoma : moving forward
BNIP3+ fibroblasts associated with hypoxia and inflammation predict prognosis and immunotherapy response in pancreatic ductal adenocarcinoma
Barriers and opportunities in pancreatic cancer immunotherapy
Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma
Novel prognostic gene signature for pancreatic ductal adenocarcinoma based on hypoxia
Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy
Cellular immunotherapy of pancreatic ductal adenocarcinoma: Discovery and evaluation of novel target candidates
Correction to: Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy
Clinical immunotherapy in pancreatic cancer
Plasticity-induced repression of Irf6 underlies acquired resistance to cancer immunotherapy in pancreatic ductal adenocarcinoma
Models of pancreatic ductal adenocarcinoma
Novel tumor suppressors in pancreatic adenocarcinoma